<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6382839</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">30787382</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">6382839</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">38990</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1038/s41598-019-38990-0</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Mean rating data for disorder-related and neutral scripts on the dimensions of anxiety, arousal, valence, and ability to imagine the scripts.</table-caption><table-wrap-foot>Note. PD, panic disorder; HC, healthy controls; M, mean; SD, standard deviation.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table 1</label><caption><p>Mean rating data for disorder-related and neutral scripts on the dimensions of anxiety, arousal, valence, and ability to imagine the scripts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>Script valence</th><th>Anxiety M (SD)</th><th>Arousal M (SD)</th><th>Valence M (SD)</th><th>Ability to imagine the scripts M (SD)</th></tr></thead><tbody><tr><td rowspan="2">PD patients</td><td>Disorder-related</td><td>5.34 (1.66)</td><td>5.61 (1.45)</td><td>3.06 (0.90)</td><td>82.15 (6.93)</td></tr><tr><td>Neutral</td><td>2.39 (0.96)</td><td>3.02 (1.14)</td><td>5.25 (0.84)</td><td>79.95 (6.88)</td></tr><tr><td rowspan="2">HC</td><td>Disorder-related</td><td>2.07 (1.45)</td><td>2.64 (1.59)</td><td>4.40 (1.46)</td><td>76.68 (9.80)</td></tr><tr><td>Neutral</td><td>1.11 (0.21)</td><td>1.46 (0.55)</td><td>5.91 (1.14)</td><td>80.04 (9.46)</td></tr><tr><td rowspan="2">Overall</td><td>Disorder-related</td><td>3.70 (2.26)</td><td>4.12 (2.13)</td><td>3.73 (1.38)</td><td>79.42 (8.81)</td></tr><tr><td>Neutral</td><td>1.75 (0.94)</td><td>2.24 (1.19)</td><td>5,58 (1.04)</td><td>79.99 (8.15)</td></tr><tr><td>PD patients</td><td>Across valence</td><td>3.86 (2.00)</td><td>4.31 (1.84)</td><td>4.15 (1.40)</td><td>78.36 (9.64)</td></tr><tr><td>HC</td><td>Across valence</td><td>1.59 (1.13)</td><td>2.05 (1.32)</td><td>5.15 (1.50)</td><td>81.05 (6.89)</td></tr></tbody></table><table-wrap-foot><p>Note. PD, panic disorder; HC, healthy controls; M, mean; SD, standard deviation.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Mean rating data for disorder-related and neutral scripts on the dimensions of anxiety, arousal, valence, and ability to imagine the scripts.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>Script valence</th><th>Anxiety M (SD)</th><th>Arousal M (SD)</th><th>Valence M (SD)</th><th>Ability to imagine the scripts M (SD)</th></tr></thead><tbody><tr><td rowspan="2">PD patients</td><td>Disorder-related</td><td>5.34 (1.66)</td><td>5.61 (1.45)</td><td>3.06 (0.90)</td><td>82.15 (6.93)</td></tr><tr><td>Neutral</td><td>2.39 (0.96)</td><td>3.02 (1.14)</td><td>5.25 (0.84)</td><td>79.95 (6.88)</td></tr><tr><td rowspan="2">HC</td><td>Disorder-related</td><td>2.07 (1.45)</td><td>2.64 (1.59)</td><td>4.40 (1.46)</td><td>76.68 (9.80)</td></tr><tr><td>Neutral</td><td>1.11 (0.21)</td><td>1.46 (0.55)</td><td>5.91 (1.14)</td><td>80.04 (9.46)</td></tr><tr><td rowspan="2">Overall</td><td>Disorder-related</td><td>3.70 (2.26)</td><td>4.12 (2.13)</td><td>3.73 (1.38)</td><td>79.42 (8.81)</td></tr><tr><td>Neutral</td><td>1.75 (0.94)</td><td>2.24 (1.19)</td><td>5,58 (1.04)</td><td>79.99 (8.15)</td></tr><tr><td>PD patients</td><td>Across valence</td><td>3.86 (2.00)</td><td>4.31 (1.84)</td><td>4.15 (1.40)</td><td>78.36 (9.64)</td></tr><tr><td>HC</td><td>Across valence</td><td>1.59 (1.13)</td><td>2.05 (1.32)</td><td>5.15 (1.50)</td><td>81.05 (6.89)</td></tr></tbody></table></div>Note. PD, panic disorder; HC, healthy controls; M, mean; SD, standard deviation.</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Region of interest analysis: Significant activations during imagination of disorder-related vs. neutral scripts.</table-caption><table-wrap-foot>Note. PD, panic disorder; HC, healthy controls; vmPFC, ventromedial prefrontal cortex; vlPFC, ventrolateral prefrontal cortex; dmPFC, dorsomedial prefrontal cortex; dlPFC, dorsolateral prefrontal cortex; dPCC, posterior cingulate cortex; rACC, rostral anterior cingulate cortex; L, left; R, right; (x, y, z), Talairach coordinates of maximally activated voxel. If not stated otherwise activations listed were calculated at p &lt; 0.05 (corrected), *p &lt; 0.005 (uncorrected).</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table 2</label><caption><p>Region of interest analysis: Significant activations during imagination of disorder-related vs. neutral scripts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Region</th><th rowspan="2">Lateralization</th><th colspan="3">Talairach coordinates of peak voxel</th><th rowspan="2">mm<sup>3</sup></th><th rowspan="2">Maximum t-value</th></tr><tr><th>x</th><th>y</th><th>z</th></tr></thead><tbody><tr><td colspan="7"><bold>PD &gt; HC</bold></td></tr><tr><td>Amygdala</td><td>R</td><td>24</td><td>−3</td><td>19</td><td>144</td><td>3.37</td></tr><tr><td>Brainstem*</td><td>R</td><td>3</td><td>−20</td><td>−18</td><td>16</td><td>3.00</td></tr><tr><td colspan="7"><bold>HC &gt; PD</bold></td></tr><tr><td>vmPFC</td><td>R</td><td>14</td><td>61</td><td>−4</td><td>408</td><td>−4.13</td></tr><tr><td>vlPFC</td><td>L</td><td>−27</td><td>40</td><td>3</td><td>1184</td><td>−4.45</td></tr><tr><td>vlPFC</td><td>R</td><td>22</td><td>55</td><td>5</td><td>448</td><td>−3.69</td></tr><tr><td>dmPFC</td><td>L</td><td>−4</td><td>62</td><td>11</td><td>208</td><td>−3.55</td></tr><tr><td>dlPFC</td><td>R</td><td>31</td><td>10</td><td>33</td><td>168</td><td>−3.28</td></tr><tr><td>dPCC</td><td>R</td><td>14</td><td>−44</td><td>38</td><td>72</td><td>−3.33</td></tr><tr><td>rACC</td><td>L</td><td>−11</td><td>32</td><td>−7</td><td>168</td><td>−3.03</td></tr><tr><td>rACC</td><td>R</td><td>7</td><td>31</td><td>−6</td><td>592</td><td>−3.47</td></tr></tbody></table><table-wrap-foot><p>Note. PD, panic disorder; HC, healthy controls; vmPFC, ventromedial prefrontal cortex; vlPFC, ventrolateral prefrontal cortex; dmPFC, dorsomedial prefrontal cortex; dlPFC, dorsolateral prefrontal cortex; dPCC, posterior cingulate cortex; rACC, rostral anterior cingulate cortex; L, left; R, right; (x, y, z), Talairach coordinates of maximally activated voxel. If not stated otherwise activations listed were calculated at p &lt; 0.05 (corrected), *p &lt; 0.005 (uncorrected).</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Region of interest analysis: Significant activations during imagination of disorder-related vs. neutral scripts.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Region</th><th rowspan="2">Lateralization</th><th colspan="3">Talairach coordinates of peak voxel</th><th rowspan="2">mm3</th><th rowspan="2">Maximum t-value</th></tr><tr><th>x</th><th>y</th><th>z</th></tr></thead><tbody><tr><td colspan="7">PD &gt; HC</td></tr><tr><td>Amygdala</td><td>R</td><td>24</td><td>−3</td><td>19</td><td>144</td><td>3.37</td></tr><tr><td>Brainstem*</td><td>R</td><td>3</td><td>−20</td><td>−18</td><td>16</td><td>3.00</td></tr><tr><td colspan="7">HC &gt; PD</td></tr><tr><td>vmPFC</td><td>R</td><td>14</td><td>61</td><td>−4</td><td>408</td><td>−4.13</td></tr><tr><td>vlPFC</td><td>L</td><td>−27</td><td>40</td><td>3</td><td>1184</td><td>−4.45</td></tr><tr><td>vlPFC</td><td>R</td><td>22</td><td>55</td><td>5</td><td>448</td><td>−3.69</td></tr><tr><td>dmPFC</td><td>L</td><td>−4</td><td>62</td><td>11</td><td>208</td><td>−3.55</td></tr><tr><td>dlPFC</td><td>R</td><td>31</td><td>10</td><td>33</td><td>168</td><td>−3.28</td></tr><tr><td>dPCC</td><td>R</td><td>14</td><td>−44</td><td>38</td><td>72</td><td>−3.33</td></tr><tr><td>rACC</td><td>L</td><td>−11</td><td>32</td><td>−7</td><td>168</td><td>−3.03</td></tr><tr><td>rACC</td><td>R</td><td>7</td><td>31</td><td>−6</td><td>592</td><td>−3.47</td></tr></tbody></table></div>Note. PD, panic disorder; HC, healthy controls; vmPFC, ventromedial prefrontal cortex; vlPFC, ventrolateral prefrontal cortex; dmPFC, dorsomedial prefrontal cortex; dlPFC, dorsolateral prefrontal cortex; dPCC, posterior cingulate cortex; rACC, rostral anterior cingulate cortex; L, left; R, right; (x, y, z), Talairach coordinates of maximally activated voxel. If not stated otherwise activations listed were calculated at p &lt; 0.05 (corrected), *p &lt; 0.005 (uncorrected).</transformed-table></extracted-table><extracted-table><table-id>Tab3</table-id><table-label>Table 3</table-label><table-caption>Demographics and questionnaire measures.</table-caption><table-wrap-foot>Note. PD, panic disorder patients; HC, healthy controls; M, mean; SD, standard deviation; HAM-A, Hamilton Anxiety Rating-Scale116: &lt;17: mild anxiety symptoms; STAI-T, State-Trait Anxiety Inventory117: &gt;40: pathologically increased level of anxiety; BDI-II, Beck Depression Inventory118: &gt;13–19: mild depressive. symptoms; ASI, Anxiety Sensitivity Index119: 0–64, (no standard value); PAS, Panic and Agoraphobia Scale103: 19–28: moderately severe PD.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table 3</label><caption><p>Demographics and questionnaire measures.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Range</th><th>PD M (SD)</th><th>HC M (SD)</th><th><italic>t</italic>-value</th><th><italic>p</italic>-value</th></tr></thead><tbody><tr><td>Age in years</td><td>19–35</td><td>24.12 (4.55)</td><td>24.35 (3.37)</td><td>0.17</td><td>0.865</td></tr><tr><td>Years of education</td><td>10–13</td><td>12.47 (0.72)</td><td>12.59 (0.80)</td><td>0.45</td><td>0.654</td></tr><tr><td>HAM-A</td><td>0–56</td><td>13.29 (7.76)</td><td>0.24 (0.56)</td><td>6.92</td><td>&lt;0.001</td></tr><tr><td>STAI-Trait</td><td>20–80</td><td>46.53 (8.02)</td><td>30.24 (6.97)</td><td>6.33</td><td>&lt;0.001</td></tr><tr><td>BDI-II</td><td>0–63</td><td>14.29 (6.86)</td><td>1.59 (2.48)</td><td>7.18</td><td>&lt;0.001</td></tr><tr><td>ASI</td><td>0–64</td><td>49.00 (12.76)</td><td>13.35 (11.01)</td><td>8.72</td><td>&lt;0.001</td></tr><tr><td>PAS</td><td>0–52</td><td>21.82 (6.31)</td><td>0.18 (0.53)</td><td>14.10</td><td>&lt;0.001</td></tr></tbody></table><table-wrap-foot><p>Note. PD, panic disorder patients; HC, healthy controls; M, mean; SD, standard deviation; HAM-A, Hamilton Anxiety Rating-Scale<sup><xref ref-type="bibr" rid="CR116">116</xref></sup>: &lt;17: mild anxiety symptoms; STAI-T, State-Trait Anxiety Inventory<sup><xref ref-type="bibr" rid="CR117">117</xref></sup>: &gt;40: pathologically increased level of anxiety; BDI-II, Beck Depression Inventory<sup><xref ref-type="bibr" rid="CR118">118</xref></sup>: &gt;13–19: mild depressive. symptoms; ASI, Anxiety Sensitivity Index<sup><xref ref-type="bibr" rid="CR119">119</xref></sup>: 0–64, (no standard value); PAS, Panic and Agoraphobia Scale<sup><xref ref-type="bibr" rid="CR103">103</xref></sup>: 19–28: moderately severe PD.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographics and questionnaire measures.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>Range</th><th>PD M (SD)</th><th>HC M (SD)</th><th>t-value</th><th>p-value</th></tr></thead><tbody><tr><td>Age in years</td><td>19–35</td><td>24.12 (4.55)</td><td>24.35 (3.37)</td><td>0.17</td><td>0.865</td></tr><tr><td>Years of education</td><td>10–13</td><td>12.47 (0.72)</td><td>12.59 (0.80)</td><td>0.45</td><td>0.654</td></tr><tr><td>HAM-A</td><td>0–56</td><td>13.29 (7.76)</td><td>0.24 (0.56)</td><td>6.92</td><td>&lt;0.001</td></tr><tr><td>STAI-Trait</td><td>20–80</td><td>46.53 (8.02)</td><td>30.24 (6.97)</td><td>6.33</td><td>&lt;0.001</td></tr><tr><td>BDI-II</td><td>0–63</td><td>14.29 (6.86)</td><td>1.59 (2.48)</td><td>7.18</td><td>&lt;0.001</td></tr><tr><td>ASI</td><td>0–64</td><td>49.00 (12.76)</td><td>13.35 (11.01)</td><td>8.72</td><td>&lt;0.001</td></tr><tr><td>PAS</td><td>0–52</td><td>21.82 (6.31)</td><td>0.18 (0.53)</td><td>14.10</td><td>&lt;0.001</td></tr></tbody></table></div>Note. PD, panic disorder patients; HC, healthy controls; M, mean; SD, standard deviation; HAM-A, Hamilton Anxiety Rating-Scale???: &lt;17: mild anxiety symptoms; STAI-T, State-Trait Anxiety Inventory???: &gt;40: pathologically increased level of anxiety; BDI-II, Beck Depression Inventory???: &gt;13–19: mild depressive. symptoms; ASI, Anxiety Sensitivity Index???: 0–64, (no standard value); PAS, Panic and Agoraphobia Scale???: 19–28: moderately severe PD.</transformed-table></extracted-table></extracted-tables-set>